561 studies found for:    Open Studies | "Hormones"
Show Display Options
Rank Status Study
21 Unknown  Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
Intervention:
22 Unknown  Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
23 Not yet recruiting A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer
Conditions: Breast Cancer;   Hormone Receptor Positive Tumor;   Early-Stage Breast Carcinoma
Interventions: Drug: Abemaciclib;   Drug: Loperamide;   Drug: Anastrozole
24 Not yet recruiting Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Exemestane;   Drug: Everolimus
25 Recruiting Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.
Conditions: Breast Neoplasms;   Breast Diseases;   Neoplasms;   Neoplasms by Site;   Fulvestrant;   Antineoplastic Agents;   Antineoplastic Agents, Hormonal;   Estrogen Receptor Antagonists;   Hormone Antagonists;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Molecular Mechanisms of Pharmacological Action;   Pharmacologic Actions;   Therapeutic Use
Interventions: Drug: Ribociclib;   Drug: fulvestrant;   Drug: Ribociclib placebo
26 Recruiting Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina
Condition: Advanced Hormone Dependent Prostate Cancer
Intervention: Drug: Firmagon® (degarelix)
27 Recruiting Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (VRS-317)
Conditions: Pediatric Growth Hormone Deficiency;   Growth Disorders
Intervention: Drug: VRS-317
28 Not yet recruiting Bone Structure in Patients With Adult Onset Growth Hormone Deficiency Assessed Using High Resolution Peripheral Quantitative Computed Tomography
Condition: Adult Onset Growth Hormone Deficiency
Intervention:
29 Recruiting Versartis Long-Term Extension Study of VRS-317
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: VRS-317
30 Recruiting Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With Poor Prognosis, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving 3 Years of Adjuvant Hormone Therapy
Conditions: Primary Non-metastatic Breast Cancer;   Who Remain Disease-free After Receiving at Least 1 Year of Adjuvant Hormone Therapy
Interventions: Drug: Everolimus;   Drug: Placebo
31 Recruiting Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Condition: Adults Growth Hormone Deficiency.
Interventions: Drug: Pegvisomant;   Drug: Regular insulin
32 Recruiting The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test
Conditions: Precocious Puberty;   Growth Hormone Tests
Intervention: Behavioral: Presence of medical clown during endocrine test
33 Recruiting Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Conditions: Breast Cancer Recurrent;   HER2/Neu-negative Carcinoma of Breast;   Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Bevacizumab;   Drug: Capecitabine;   Drug: Everolimus;   Drug: Exemestane;   Other: Patient questionaires
34 Recruiting Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast;   Metastatic Breast Cancer
Intervention: Drug: Everolimus plus Exemestane
35 Recruiting Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Conditions: Pituitary Neoplasms;   Prolactinoma;   ACTH-Secreting Pituitary Adenoma;   Gigantism;   Growth Hormone-Secreting Pituitary Adenoma
Intervention: Other: Educational Intervention
36 Recruiting Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Recurrent Prostate Carcinoma;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Abiraterone Acetate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Prednisone
37 Recruiting Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: mifepristone;   Other: laboratory biomarker analysis;   Other: pharmacological study
38 Not yet recruiting Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Malignant Neoplasm in the Soft Tissues;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Biological: Pembrolizumab;   Biological: pTVG-HP Plasmid DNA Vaccine
39 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone
40 Recruiting CYT107 With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Biological: glycosylated recombinant human interleukin-7;   Other: laboratory biomarker analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years